Your browser doesn't support javascript.
loading
Introduction and transmission of SARS-CoV-2 lineage B.1.1.7, Alpha variant, in Denmark.
Michaelsen, Thomas Y; Bennedbæk, Marc; Christiansen, Lasse E; Jørgensen, Mia S F; Møller, Camilla H; Sørensen, Emil A; Knutsson, Simon; Brandt, Jakob; Jensen, Thomas B N; Chiche-Lapierre, Clarisse; Collados, Emilio F; Sørensen, Trine; Petersen, Celine; Le-Quy, Vang; Sereika, Mantas; Hansen, Frederik T; Rasmussen, Morten; Fonager, Jannik; Karst, Søren M; Marvig, Rasmus L; Stegger, Marc; Sieber, Raphael N; Skov, Robert; Legarth, Rebecca; Krause, Tyra G; Fomsgaard, Anders; Albertsen, Mads.
Afiliação
  • Michaelsen TY; Department of Chemistry and Bioscience, Aalborg University, Aalborg, Denmark.
  • Bennedbæk M; Centre of Excellence for Health, Immunity and Infection (CHIP), Department of Infectious Diseases, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Christiansen LE; Department of Applied Mathematics and Computer Science, Technical University of Denmark, Lyngby, Denmark.
  • Jørgensen MSF; Infectious Disease Epidemiology & Prevention, Statens Serum Institut, Copenhagen, Denmark.
  • Møller CH; Infectious Disease Preparedness, Statens Serum Institut, Copenhagen, Denmark.
  • Sørensen EA; Department of Chemistry and Bioscience, Aalborg University, Aalborg, Denmark.
  • Knutsson S; Department of Chemistry and Bioscience, Aalborg University, Aalborg, Denmark.
  • Brandt J; Department of Chemistry and Bioscience, Aalborg University, Aalborg, Denmark.
  • Jensen TBN; Department of Chemistry and Bioscience, Aalborg University, Aalborg, Denmark.
  • Chiche-Lapierre C; Department of Chemistry and Bioscience, Aalborg University, Aalborg, Denmark.
  • Collados EF; Department of Chemistry and Bioscience, Aalborg University, Aalborg, Denmark.
  • Sørensen T; Department of Chemistry and Bioscience, Aalborg University, Aalborg, Denmark.
  • Petersen C; Department of Chemistry and Bioscience, Aalborg University, Aalborg, Denmark.
  • Le-Quy V; Unit for Research Data Services (CLAAUDIA), Aalborg University, Aalborg, Denmark.
  • Sereika M; Department of Chemistry and Bioscience, Aalborg University, Aalborg, Denmark.
  • Hansen FT; Department of Chemistry and Bioscience, Aalborg University, Aalborg, Denmark.
  • Rasmussen M; Department of Virus & Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark.
  • Fonager J; Department of Virus & Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark.
  • Karst SM; Department of Virus & Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark.
  • Marvig RL; Center for Genomic Medicine, Rigshospitalet, Copenhagen, Denmark.
  • Stegger M; Department of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark.
  • Sieber RN; Department of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark.
  • Skov R; Infectious Disease Preparedness, Statens Serum Institut, Copenhagen, Denmark.
  • Legarth R; Infectious Disease Epidemiology & Prevention, Statens Serum Institut, Copenhagen, Denmark.
  • Krause TG; Infectious Disease Preparedness, Statens Serum Institut, Copenhagen, Denmark.
  • Fomsgaard A; Department of Virus & Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark.
  • Albertsen M; Department of Chemistry and Bioscience, Aalborg University, Aalborg, Denmark. ma@bio.aau.dk.
Genome Med ; 14(1): 47, 2022 05 04.
Article em En | MEDLINE | ID: mdl-35505393

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Limite: Humans País/Região como assunto: Europa Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Limite: Humans País/Região como assunto: Europa Idioma: En Ano de publicação: 2022 Tipo de documento: Article